Abstract Competition Winners

First Place 

Abstract #8 – University of California, Los Angeles

Title: PSMA PET/CT–based Patterns of Prostate Fossa Recurrence after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy

Submitted by: Ida Sonni, MD, University of California, Los Angeles

Second Place

Abstract #3 – Cleveland Clinic

Title: True Positive 18F-rhPSMA-7.3 Lesions in Patients with Prostate Cancer Recurrence with Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter, SPOTLIGHT Study

Submitted by: Andrei Purysko, MD, Cleveland Clinic

Third Place

Abstract #5 – Avenda Health

Title: A Validated Prostate Cancer Probability Map To Aid In Focal Treatment Planning

Submitted by: Alan Priester, PhD, Avenda Health

Selected Abstracts (In Order of Submission)

Abstract #1 – Lantheus

Author’s Release is Pending

Abstract #2 – Telix Pharmaceuticals

Role of Androgen Receptor Blockade in PSMA Expression Using 68Ga-PSMA-11 PET/CT Imaging in Patients with Metastatic Castrate Resistant Prostate Cancer

View Here

Abstract #3 – Cleveland Clinic

True Positive 18F-rhPSMA-7.3 Lesions in Patients with Prostate Cancer Recurrence with Negative Conventional Imaging: Results from the Prospective, Phase 3, Multicenter, SPOTLIGHT Study

View Here

Abstract #4 – Stanford University

Modified PROMISE Criteria for Standardized Interpretation of GRPR-targeted PET

View Here

Abstract #5 – Avenda Health

A Validated Prostate Cancer Probability Map To Aid In Focal Treatment Planning

View Here

Abstract #6 – Avenda Health

A Novel AI-Derived Metric Identifies Optimal Candidates for Focal Therapy of Prostate Cancer and Accurately Predicts Treatment Margin Efficacy

View Here

Abstract #7 – Yale School of Medicine

Author’s Release is Pending

Abstract #8 – University of California, Los Angeles

PSMA PET/CT–based Patterns of Prostate Fossa Recurrence after Radical Prostatectomy: Clinical Implications for Salvage Radiation Therapy

View Here

Call for Abstracts
6th Global Summit